Trade GlaxoSmithKline PLC - GSKl CFD

Add to favourite

16.515

0.82%

0.065

Low: 16.325

High: 16.52

Market Trading Hours* (UTC) Opens on Monday at 07:00

Mon - Fri: 07:00 - 11:00 11:03 - 15:30

Summary
Historical Data

Trading сonditions

Spread

0.065

Long position overnight fee

-0.02529%

Short position overnight fee

0.003373%

Overnight fee time

21:00 (UTC)

Min traded quantity

0.1

Currency

GBP

Margin

Stock exchange

United Kingdom of Great Britain and Northern Ireland

Commission on trade

Key Stats

Prev. Close	16.38
Open	16.42
1-Year Change	9.94%
Day's Range	16.325 - 16.52

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 26, 2024	16.515	0.240	1.47%	16.275	16.525	16.275
Apr 25, 2024	16.380	-0.020	-0.12%	16.400	16.535	16.320
Apr 24, 2024	16.350	-0.120	-0.73%	16.470	16.580	16.100
Apr 23, 2024	16.490	0.010	0.06%	16.480	16.535	16.340
Apr 22, 2024	16.385	0.215	1.33%	16.170	16.450	16.080
Apr 19, 2024	15.980	0.225	1.43%	15.755	15.980	15.725
Apr 18, 2024	15.805	-0.090	-0.57%	15.895	15.935	15.775
Apr 17, 2024	15.770	-0.145	-0.91%	15.915	15.985	15.740
Apr 16, 2024	16.060	-0.160	-0.99%	16.220	16.240	15.910
Apr 15, 2024	16.390	0.110	0.68%	16.280	16.450	16.280
Apr 12, 2024	16.410	0.115	0.71%	16.295	16.495	16.230
Apr 11, 2024	16.260	0.100	0.62%	16.160	16.395	16.150
Apr 10, 2024	16.160	-0.025	-0.15%	16.185	16.245	16.015
Apr 9, 2024	16.090	0.000	0.00%	16.090	16.150	16.010
Apr 8, 2024	16.155	-0.065	-0.40%	16.220	16.255	16.130
Apr 5, 2024	16.235	0.210	1.31%	16.025	16.265	15.885
Apr 4, 2024	16.290	-0.220	-1.33%	16.510	16.685	16.290
Apr 3, 2024	16.480	-0.105	-0.63%	16.585	16.620	16.380
Apr 2, 2024	16.340	-0.245	-1.48%	16.585	16.895	16.340
Mar 28, 2024	16.910	0.010	0.06%	16.900	17.105	16.900

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

GSK Company profile

GlaxoSmithKline PLC - GSK CFD

GlaxoSmithKline (GSK) is a global healthcare company focussed in pharmaceuticals, vaccine development and consumer healthcare products.

The company began as an apothecary shop in London in 1715. Today, GlaxoSmithKline is headquartered in Brentford, England, with regional offices in the US and Singapore. GlaxoSmithKline’s primary listing is on the London Stock Exchange under the ticker symbol ‘GSK’. The GSK stock price in the form of American depositary shares is listed on the New York Stock Exchange.

GlaxoSmithKline’s pharmaceutical business covers a broad portfolio of medicines in respiratory, HIV, immuno-inflammation and oncology. The company has a leadership position in respiratory disease medicines. GlaxoSmithKline’s HIV business is managed through its unit ViiV Healthcare, with Pfizer and Shionogi as minority shareholders.

In addition to respiratory and HIV treatments, the company has a portfolio of pharmaceutical products for the treatment of conditions such as lupus, urology and anti-infectives.

Its Established Products Portfolio (EPP) includes mature medicines in the areas of anti-infectives, allergy, central nervous system, dermatology, respiratory and urology. These products are an important part of our Emerging Markets business.

GlaxoSmithKline is actively researching the World Health Organisation’s three priority diseases - HIV/AIDS, tuberculosis and malaria.

GlaxoSmithKline is also one of the world’s largest vaccine companies with a portfolio of more than 20 vaccines. The company has 12 vaccine manufacturing sites around the world. One of its four global R&D centres is dedicated to mRNA technology.

GlaxoSmithKline’s consumer healthcare business has portfolio of brands that include Sensodyne, Parodontax, Polident, Advil, Voltaire, Panadol, Striven, Theraflu and Centrum across oral health, pain relief, cold, flu and allergy, digestive health, and vitamins, mineral and supplements segments. GlaxoSmithKline is set to spin-off its consumer healthcare business into an independent company under the name ‘Haleon’.’

The company pays dividends on a quarterly basis, in July, October, January and April.
Follow the GlaxoSmithKline stock price live at Capital.com today.

Industry:

Pharmaceuticals (NEC)

980 Great West Road
BRENTFORD
MIDDLESEX TW8 9GS
GB

News

We’re partnering with Newsquawk

Filter out the noise and focus on the news that matters.

08:32, 23 April 2024

US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft

The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.

15:56, 22 April 2024

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024